Researchers from Public Assistance - Paris Hospitals (AP-HP) Describe Research in Lupus (A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter)

MLA

“Researchers from Public Assistance - Paris Hospitals (AP-HP) Describe Research in Lupus (A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter).” Health & Medicine Week, 18 June 2021, p. 6202. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.665074083&authtype=sso&custid=ns315887.

APA

Researchers from Public Assistance - Paris Hospitals (AP-HP) Describe Research in Lupus (A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter). (2021, June 18). Health & Medicine Week, 6202.

Chicago

Health & Medicine Week. 2021. “Researchers from Public Assistance - Paris Hospitals (AP-HP) Describe Research in Lupus (A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter),” June 18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.665074083&authtype=sso&custid=ns315887.